Literature DB >> 20591306

Coexistence of Mandibular Arteriovenous Malformation and Cerebellar Arteriovenous Malformation. An Example of Cerebrofacial Arteriovenous Metameric Syndrome Type III.

C Haw1, D Sarma, K Ter Brugge.   

Abstract

SUMMARY: We describe a patient with cerebellar and mandibular arteriovenous malformations who initially presented with oral haemorrhage and then subsequently had a cerebellar haemorrhage. This is the second reported case of cerebrofacial arteriovenous metameric syndrome type III (CAMS III) in the literature and we discuss the role of homeobox genes in craniofacial development and angiogenesis.

Entities:  

Year:  2004        PMID: 20591306      PMCID: PMC3547413          DOI: 10.1177/159101990300900112

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  5 in total

1.  Unilateral retinocephalic vascular malformations.

Authors:  J Théron; T H Newton; W F Hoyt
Journal:  Neuroradiology       Date:  1974       Impact factor: 2.804

Review 2.  Craniofacial abnormalities induced by the ectopic expression of homeobox genes.

Authors:  J Whiting
Journal:  Mutat Res       Date:  1997-12-12       Impact factor: 2.433

3.  Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification.

Authors:  J J Bhattacharya; C B Luo; D C Suh; H Alvarez; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

4.  Homeobox B3 promotes capillary morphogenesis and angiogenesis.

Authors:  C Myers; A Charboneau; N Boudreau
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

5.  Induction of the angiogenic phenotype by Hox D3.

Authors:  N Boudreau; C Andrews; A Srebrow; A Ravanpay; D A Cheresh
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

  5 in total
  1 in total

Review 1.  The cerebrofacial metameric syndromes: An embryological review and proposal of a novel classification scheme.

Authors:  Anthony S Larson; Waleed Brinjikji; Timo Krings; Julie B Guerin
Journal:  Interv Neuroradiol       Date:  2021-10-19       Impact factor: 1.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.